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Abstract
Background and Aims
Assessment of adiposity using dual energy x-ray absorptiometry (DXA) has been considered more advantageous in comparison to anthropometry for predicting cardio-metabolic
risk in the older population, by virtue of its ability to distinguish total and regional fat. Nonetheless, there is increasing uncertainty regarding the relative superiority of DXA and little
comparative data exist in young adults. This study aimed to identify which measure of adiposity determined by either DXA or anthropometry is optimal within a range of cardio-metabolic risk factors in young adults.

Methods and Results
1138 adults aged 20 years were assessed by DXA and standard anthropometry from the
Western Australian Pregnancy Cohort (Raine) Study. Cross-sectional linear regression
analyses were performed. Waist to height ratio was superior to any DXA measure with
HDL-C. BMI was the superior model in relation to blood pressure than any DXA measure.
Midriff fat mass (DXA) and waist circumference were comparable in relation to glucose. For
all the other cardio-metabolic variables, anthropometric and DXA measures were comparable. DXA midriff fat mass compared with BMI or waist hip ratio was the superior measure for
triglycerides, insulin and HOMA-IR.
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Conclusion
Although midriff fat mass (measured by DXA) was the superior measure with insulin sensitivity and triglycerides, the anthropometric measures were better or equal with various DXA
measures for majority of the cardio-metabolic risk factors. Our findings suggest, clinical
anthropometry is generally as useful as DXA in the evaluation of the individual cardio-metabolic risk factors in young adults.
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Introduction
The prevalence of obesity is increasing worldwide. In 2014 more than 1.9 billion adults, 18
years and older, were overweight and approximately 600 million adults were obese [1]. Excess
body fat is an established risk factor for numerous chronic diseases and premature death [2, 3].
Most studies seeking to increase the understanding of the negative influence of obesity have
been based on body mass index (BMI). However, BMI does not reflect total body adiposity
because it cannot differentiate between lean and fat mass of an individual. Alternative measures
such as waist circumference or waist-height ratio may be better clinical indicators of adiposity
[4].
Dual energy x-ray absorptiometry (DXA) is the gold standard for the diagnosis of osteoporosis [5] and has increasingly been used for the diagnosis/management of overweight and obesity and in clinical research in cardiovascular disease [6–8]. The question arises as to whether
the use of DXA in the management of overweight and obesity is justified in terms of cost and/
or complexity, in return for any clear-cut scientific or clinical value. There are commercial drivers for the use of DXA; for example in the USA a patient can expect to pay approximately $100
US in the public health setting or $250 US within the private health sector for a DXA scan without rebate [9]. There has been a 65% decline in Medicare reimbursement of DXA bone mineral
density testing in the non-facility setting, from approximately $140 in 2006 to $50 in 2014 [10].
At this lower level, providers of DXA scans are finding it more difficult to cover the operating
costs, due to funding cuts [11]. Therefore, there has been some motivation to find another use
for DXA that may be clinically relevant to health professionals, particularly to allow for early
identification and intervention of individuals in relation to obesity and cardio-metabolic
health.
The dominance and differential effects of DXA over anthropometry for estimating the presence of cardio-metabolic risk has not been clearly established. Studies in middle aged adults,
which compare anthropometric and DXA adiposity measurements, have been inconsistent
with respect to the strength of associations with cardio-metabolic risk factors, most likely due
to methodological inconsistencies in defining adiposity [2, 12]. Moreover, many of these
reports only take into account estimates of total body fat percentage and not fat distribution or
abdominal fat mass 10–14. In addition, there is also a lack of reported data comparing DXA
against cardio-metabolic risk factors solely in young adult populations [4, 12].
Obesity in young adults is an important predictor for subsequent coronary disease and diabetes in middle to old age [13, 14]. Australia follows worldwide trends showing increasing levels of obesity and Type 2 diabetes in early adulthood [15]. The early identification of
individuals who are of increased risk of coronary disease and diabetes in later life has the
potential to implement lifestyle modifications that could reduce this risk. This study therefore
aimed to identify which measure of adiposity determined by either DXA (total body fat percentage, Fat Distribution Index and midriff fat mass) or anthropometry (abdominal skinfold,
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waist circumference, waist to height ratio, weight and BMI), is optimal within a range of cardio-metabolic risk factors in a sample of healthy young adults from the Western Australian
Pregnancy Cohort (Raine) Study.

Methods
Participants
The Western Australian Pregnancy Cohort (Raine) Study is a prospective population study
where pregnant women between 16 to 20 weeks gestation were recruited from King Edward
Memorial Hospital and closely located practices. The mothers gave birth to 2868 live infants.
Detailed information on the methods of the Raine Study has previously been reported [16].
The present population comprised 1273 adults from the Raine Study who attended the 20 year
old survey. Written informed consent was obtained from the participants. Ethics approval for
the 20 year assessment was obtained from the Human Research Ethics Committee at the University of Western Australia.

Adult anthropometry and DXA measurements
At the 20 year follow up, height was measured by a wall mounted Stadiometer (to the nearest
0.1 cm) and weight was measured (to the nearest 100g) with participants dressed in light
clothes. Body mass index (BMI) was calculated as weight (kg) divided by the square of height
(m2). Waist circumference was evaluated at the umbilicus level and hip circumference at the
level of the maximum posterior extension of the buttocks with a tape measure (to the nearest
0.1 cm). The abdominal skinfold was measured from a vertical skinfold immediately to the left
of the umbilicus, the suprailiac skinfold was assessed from a diagonal fold located 1 cm above
the anterior superior iliac crest and the tricep skinfold was measured from a vertical skinfold
along the midline on the back of the triceps of the right arm using a skinfold calliper (Holtain,
Crosswell, United Kingdom) [17]. All skinfold measurements were assessed twice with the
average of the skinfolds calculated. The sum of three skinfolds was calculated from the abdominal, suprailiac and tricep skinfold sites and this characterises the subcutaneous fat thickness at
different regions of the body [18]. Waist to hip and waist to height ratios were derived from the
division of waist circumference (cm) by the hip circumference (cm) and height (m),
respectively.
The study used a Norland XR-36 densitometer (Norland Medical Systems, Inc., Fort Atkinson, WI, USA) to provide estimates of whole body fat mass (g), lean mass (g), midriff fat mass
(g) (vertebrae L1—L4). Total body fat percentage was estimated as total body fat mass (g) /
total mass x 100. The Fat Distribution Index was calculated from the formula chest fat mass (g)
+ midriff fat mass (g) / pelvis fat mass (g) + left leg fat mass (g) + right leg fat mass (g) [19]. All
measurements were performed by trained research personnel.

Biochemistry and blood pressure measurements
Venous blood samples taken after an overnight fast were analysed in the PathWest Laboratory
at Royal Perth Hospital for serum glucose, insulin, total cholesterol, triglycerides, high density
lipoprotein-cholesterol (HDL-C) and high sensitivity C-reactive protein (hs-CRP) [20]. Low
density lipoprotein-cholesterol (LDL-C) was calculated using the Friedewald equation [21].
The homeostatic model assessment of insulin resistance (HOMA-IR) was calculated using the
formula: fasting insulin (μU/ml) x fasting glucose (mmol/L) / 22.5 [22]. BP was measured
using an oscillometric sphygmomanometer with the appropriate cuff size for arm circumference (DINAMAP vital signs monitor 8100, DINAMAP XL vital signs monitor or DINAMAP
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ProCare 100; GE Healthcare). Six BP readings were obtained every 2 minutes within a 10 minute time period in the supine position, after a 5 minute resting period. The average BP value
was calculated using the last five readings to obtain systolic and diastolic BP values [23].

Statistical analysis
Characteristics of the sample were summarised using means and standard deviations (SD) separately for males and females. Differences between the sexes were tested using t-tests. All
reported p values are 2-tailed and significance was set at α = 0.05.
Linear regression analyses examined the relationship between each adiposity measures and
cardio-metabolic risk factors. All models included and tested the interaction between sex and
the adiposity indicator. For each outcome, comparisons were made within the set of models,
using each adiposity measure to identify the best DXA measure related to a given cardio-metabolic risk factor and similarly for the anthropometric measures. The measures identified as
best from each of these two sets (DXA and anthropometry) were then compared. For example
the model of DXA midriff fat mass and triglycerides was compared with the model of waist/
height and triglycerides. Given that these models were not nested within each other, likelihood
ratio tests were not appropriate to formally compare models. Thus the Akaike Information Criterion (AIC) was utilised [24]. As required, all models for a particular outcome were constructed on a static sample determined by complete data on all adiposity measures. For any
given outcome, the model with the minimum AIC was deemed to be the best model. Differences from the minimum AIC provide a strength of evidence comparison and the ranking of
models with respect to the best model. By calculating differences between AIC, arbitrary scaling
constants are removed allowing the application of guidelines to interpret the difference. Models
where the difference in AIC is 2 indicates substantial support that they are not different,
while support for this claim decreases as the difference in AIC increases (AIC values above 10
are considered to have no support for equivalence). The adjusted R2 for each model was also
reported. In addition to models with a single adiposity measure, combinations of anthropometric and DXA measures were explored in a similar manner. The combinations included midriff
fat mass and waist circumference, fat distribution index and BMI, and midriff fat mass and
BMI. Tobit regression (for censored data) was utilised for fasting insulin and hs-CRP due to
the lower boundary of the test [25]. All other regressions performed were ordinary linear
regression. Variables were log transformed if the values were not normally distributed (triglycerides, HDL-C, insulin, hs-CRP). Data were analysed using STATA (StataCorp, 2011. Stata
Statistical Software: release 12. College Station. TX: StataCorp, LP).

Results
Descriptive characteristics
General characteristics of body composition using DXA, anthropometry and the individual
cardio-metabolic risk factors are shown separately for females and males in Table 1.
Ethnicity in the cohort was predominantly Caucasian (93%). At 20 years of age, females had
a higher total body fat percentage, fat distribution index and midriff fat mass compared with
males (p <0.001) (Table 1). Males were taller, heavier and had a greater waist circumference
than females (all p <0.001) but had a significantly lower abdominal skinfold. Males and
females were not statistically different for waist to height ratio and BMI. All cardio-metabolic
risk factors were statistically different between males and females except for HOMA-IR and
diastolic BP. Females had lower systolic BP, triglycerides and glucose, and higher total cholesterol, HDL-C, LDL-C, insulin and hs-CRP, than males. The number of individuals in the
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Table 1. Descriptive characteristics of males and females from the Western Australian Pregnancy Cohort at 20 years of age.
Measure

Females

Males

n = 532

n = 606

p value

DXA
Total body fat percentage (%)

39.3 (8.9)

21.8 (8.7)

<0.001

17 318.2 (7 349.1)

11235.7 (6 431.0)

<0.001

1 401.7 (932.9)

1 091.0 (887.6)

<0.001

Abdominal skinfold (mm)

25.4 (8.6)

21.5 (10.2)

<0.001

Waist circumference (cm)

77.2 (13.0)

83.0 (12.2)

<0.001

Waist/height ratio

46.7 (8.0)

46.4 (6.6)

0.44

Fat distribution index (g)
Midriff fat mass (g)
Anthropometry

Height (m)

1.66 (0.1)

1.78 (0.1)

<0.001

Weight (kg)

67.1 (15.8)

78.7 (16.4)

<0.001

BMI (kg/m2)

24.4 (5.6)

24.5 (4.5)

0.71

Cholesterol (mmol/L)

4.5 (0.8)

4.2 (0.8)

<0.001

Triglycerides (mmol/L)

1.0 (0.5)

1.1 (0.6)

0.03

HDL-C (mmol/L)

1.4 (0.3)

1.2 (0.2)

<0.001

LDL-C (mmol/L)

2.6 (0.6)

2.4 (0.7)

<0.001

hs C-reactive protein (mg/L)

3.0 (5.5)

2.1 (5.8)

0.004

Glucose (mmol/L)

4.8 (0.4)

5.1 (0.4)

<0.001

Insulin (mU/L)

1.3 (0.7)

1.2 (0.7)

0.002

HOMA-IR

1.1 (1.2)

1.0 (1.4)

0.69

Systolic BP (mmHg)

111.1 (10.2)

122.3 (11.8)

<0.001

Diastolic BP (mmHg)

65.4 (7.2)

65.2 (7.8)

0.62

Biochemistry

Blood Pressure

Descriptive characteristics are presented as means and SD. BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; hs Creactive protein; high sensitivity C-reactive protein; HOMA-IR, homeostatic model assessment of insulin resistance; BP, blood pressure.
doi:10.1371/journal.pone.0162164.t001

sample with metabolic syndrome according to the revised National Cholesterol Education Program Adult Treatment Panel III guidelines [26] was 26 females (1.8%) and 47 males (3.3%).

DXA and anthropometry measures with the individual cardio-metabolic
risk factors
(i) Comparisons within DXA and anthropometric measures. Table 2 summarises the
DXA and anthropometry measures that produced the lowest AIC for each of the individual
cardio-metabolic risk factors. No statistically significant differences between the sexes in the
relationship between the adiposity measures and the cardio-metabolic risk factors were found
for any outcome. The interaction term was therefore removed and a single adiposity coefficient
applicable to both males and females was estimated. Within the DXA measures, midriff fat
mass was the superior model for all risk factors with the exception of HDL-C, hs-CRP and systolic BP. In contrast, there was considerable variation in the best anthropometric measure
across the cardio-metabolic risk factors: BMI was the best measure for systolic BP, hs-CRP,
insulin and HOMA-IR; waist to height ratio was best for triglycerides, HDL-C and LDL-C; and
abdominal skin fold was best for cholesterol and diastolic BP. Body adiposity index and sum of
skinfolds, as anthropometry measurements, were not evident to have the lowest AIC with any
of the risk factors. None of the combinations of DXA with anthropometry measures was
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Table 2. The Akaike Information Criterion differences between the best DXA and best anthropometry measures with the individual cardio-metabolic risk factors in young adults.
Adiposity indices

Best DXA
AIC R2

Best

AIC difference

Anthropometry

(DXA –

AIC R2

Anthropometry)

Cholesterol

Midriff fat mass

N = 1021

2325.3 0.08

Abdominal skinfold
2327.73 0.04

Triglycerides

Midriff fat mass*

Waist/height ratio

N = 1021

1550.2 0.10

1560.64 0.09

HDL-C

Fat distribution

Waist/height ratio*

N = 1021

343.3 0.19

331.78 0.20

LDL-C

Midriff fat mass

Waist/height ratio

N = 1021

1972.1 0.05

1971.55 0.06

hs C-reactive protein

Total body fat

BMI

-2.46
-10.49

index
11.54
0.52

percentage
N = 1021

6359.9 0.006

6362.34 0.005

Glucose

Midriff fat mass

Waist circumference

N = 1021

957.8 0.09

958.08 0.09

Insulin

Midriff fat mass*

BMI

N = 1021

2158.3 0.08

2168.08 0.07

HOMA-IR

Midriff fat mass*

BMI

N = 1021

3261.1 0.04

3270.46 0.04

Systolic BP

Fat distribution

BMI*

N = 1180

8884.8 0.27

8831.09 0.30

Diastolic BP

Midriff fat mass

Abdominal skinfold

N = 1180

8043.4 0.03

8043.73 0.003

-2.41
-0.28
-9.74
-9.36

index
53.7
-0.38

*Best adiposity measure
AIC and R2 values were derived from linear or Tobit regression models adjusted for sex (S1–S3 Tables). AIC differences were derived from the best DXA
AIC value—the best anthropometry AIC value. Differences in AIC between models of approximately 2 were considered to indicate equivalent adiposity
measures. Otherwise the model with the lowest AIC was considered superior.
AIC, Akaike information criterion; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HOMA-IR, homeostatic model
assessment of insulin resistance; hs C-reactive protein; high sensitivity C-reactive protein; BP, blood pressure; BMI, body mass index; WC, waist
circumference.
doi:10.1371/journal.pone.0162164.t002

superior to the individual DXA and anthropometry measures with any of the cardio-metabolic
risk factors.
(ii) Comparisons between the best DXA and best anthropometry measure. Differences
between the best DXA and anthropometry measure for individual cardio-metabolic risk factors
either clearly indicated the dominance of one measure (delta AIC >10) or suggested equivalence (delta AIC 2) (Table 2). The model that incorporated midriff fat mass was superior for
triglycerides, insulin and HOMA-IR. In contrast, waist-to-height ratio was the superior model
in relation to HDL-C and BMI was superior to any DXA measure in relation to systolic BP. For
all the other cardio-metabolic variables, anthropometric and DXA measures were comparable.
The adjusted R-squared values show marginal differences between the best DXA and anthropometry measures.
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Discussion
In this population cohort of young adults, clinical anthropometry measures either outperformed or were equivalent to DXA for majority of the cardio-metabolic risk factors. The exception was DXA midriff fat mass as it was superior for triglycerides, insulin and HOMA-IR.
Combinations of various DXA and anthropometry measures were no better than the individual
DXA or anthropometry. While not reported here, we found no additional value of lean body
mass measurements or a fat/lean mass ratio compared with clinical anthropometry. Our results
show the utility of anthropometry as a simple, cost-effective primary screening tool for the
identification of individuals at risk. Our data, however, do not preclude the use of DXA in relation to more focussed research questions or for a further detailed clinical assessment of
patients.
It is difficult to justify high equipment and scanning costs, burden on the individual and
reduced accessibility imposed by DXA used as a primary adiposity screening tool in a clinical
setting or for population level research into cardio-metabolic disease. In addition, several factors affecting the efficacy of DXA, include the interpretation of DXA scans which require specialised training, technician error operating equipment, the type of clothing and positioning of
the patient on the table. With worldwide health costs rapidly increasing, the use of DXA for fat
assessment is hard to justify, except in relation to a much more focussed research question and
for a more detailed clinical assessment of the patient, as a secondary screening tool. In this latter setting, other direct imaging methods such as magnetic resonance imaging, computer
tomography, ultrasound and possibly bioelectrical impedance analysis techniques can be useful
for the quantification and differentiation of subcutaneous and visceral fat tissue [27–29].
In our study, we showed that the much criticised BMI was the best measure with systolic BP
and was superior to any DXA derived measure. Height and weight were also important individual determinants of BP; however, neither was better than BMI in relation to systolic BP. In
other studies, BMI was significantly related to systolic BP among US adolescents [4] [30, 31],
the NHANES study in children found BMI was more strongly correlated with systolic BP than
DXA fat mass percentage [32]. Ito et al [33] reported the accuracy of detecting hypertension
and dyslipidaemia was comparable between BMI, waist circumference and waist to height ratio
measures and the DXA measures of total percentage fat mass and midriff fat mass percentage
in adults.
We found no other comparisons of DXA and anthropometry in relation to wide range of
cardio-metabolic risk factors in young adults from population based studies. Studies in middle
aged adults and children have also shown lack of dominance of DXA over BMI. Krachler et al
[30] found BMI had similar predictive power compared to DXA fat mass percentage and bioimpedance analysis for hypertension, impaired fasting glucose, dyslipidaemia and the metabolic syndrome, in middle aged adults. BMI and waist circumference were similarly correlated
with DXA fat mass and fat mass percentage in relation to hs-CRP, BP and fasting lipids, glucose and insulin in adults [31] and in youth aged 8–18 years of age [32]. Percentage body fat
(DXA) did not produce stronger associations in estimating components of the metabolic syndrome [34] and cardiovascular risk factors than BMI and skinfold thickness in youth [35]. Our
findings on hs-CRP contrast with those of Vega et al [36] who observed that DXA total body
fat percentage was better correlated with hs-CRP than BMI, in middle-aged US adults.
The strengths of this study include data from a large sample population within a narrow age
range and a breadth of measures evaluating adiposity using DXA and anthropometry. In addition, we examined an array of cardio-metabolic risk factors, in contrast to most other studies
which had a narrower focus. A robust statistical approach was used to compare the performance of the adiposity measures within each outcome. Limitations of this study include its
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cross-sectional nature and the DXA instrument utilised cannot distinguish between visceral
adipose tissue and subcutaneous fat adipose tissue. Therefore, we could not separately analyse
these two components of adiposity. Additionally, the Norland software used in this study does
not differentiate between abdominal visceral and subcutaneous fat. However, as the Hologic
DXA software can differentiate between these compartments and our findings may not be
applicable to all DXA machine models.
Overall our findings add to the weight of evidence suggesting that anthropometry measures
are generally as useful as DXA in the evaluation of the individual cardio-metabolic risk factors.
Anthropometry offers the advantages of technical simplicity, convenience, and a lower cost
compared with DXA. Anthropometry has a great utility as a cost effective primary screening
tool of excess adiposity and allows for the early identification of individuals at risk.
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(PDF)
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